1 active not recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
Follow BNT327 Equivalent Q3W Dose: new trials by email Literature Review of BNT327 Equivalent Q3W Dose trials Research Report on BNT327 Equivalent Q3W Dose
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Preliminary Effectiveness of BNT327, an Investigational Therapy for Breast Cancer, When Given in Combination With Chemotherapy BNT327 Dose Level 1 (DL1), BNT327 Dose Level 1 (DL2), Nab-placlitaxel - Locally Advanced Breast Cancer, Triple Negative Breast Cancer | Phase 2 | Active not recruiting | BioNTech SE | 83 | 2024-08-26 | 2026-06-30 |
Triple Negative Breast Neoplasms (1)
BioNTech SE (1)
Australia (1) · Turkey (Türkiye) (1) · United Kingdom (1) · United States (1)